The previous was only top line data, this should provide in depth analysis with the level of detail similar to the Autism study. I'm looking for any comparisons with Daybue trial results data.
Remarkable how unexcited the market is over what can only be described as positive data.
- Forums
- ASX - By Stock
- NTI
- Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint
Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint, page-12
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
7.0¢ |
Change
-0.003(4.11%) |
Mkt cap ! $71.21M |
Open | High | Low | Value | Volume |
7.3¢ | 7.3¢ | 7.0¢ | $56.73K | 797.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 36397 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.069 |
2 | 79117 | 0.068 |
2 | 395000 | 0.067 |
4 | 258292 | 0.065 |
6 | 617165 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 36397 | 1 |
0.076 | 66000 | 1 |
0.077 | 42000 | 1 |
0.080 | 50000 | 1 |
0.081 | 20000 | 1 |
Last trade - 14.51pm 29/07/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |